Last Updated : March 29, 2019
Details
FilesProject Line:
Health Technology Review
Project Number:
HO0002-000 - HE0021-000
This project reviewed the evidence on the administration of repeated courses of rituximab as regularly scheduled treatment or at extended non-regular intervals to prevent relapses or flares in patients who have had an initial response with rituximab.
Files
Last Updated : March 29, 2019